Medpace Holdings Inc
Veridion Score
Composite trend over time
Why is MEDP moving today?
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for MEDP.
MEDP insider activity
Medpace Holdings Inc
2 insiders bought in the last 90 days
Net selling: -$302.9M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | 2026-05-28 | EWALD STEPHEN P | Insider | sell | $450.00 | 16,349 | 20,343 | $7.4M | SEC Form 4 |
| 2026-06-01 | 2026-05-28 | EWALD STEPHEN P | Insider | buy | $138.87 | 16,349 | 36,692 | $2.3M | SEC Form 4 |
| 2026-04-28 | 2026-04-24 | Brady Kevin M. | Insider | buy | $138.87 | 7,000 | 12,830 | $972K | SEC Form 4 |
| 2026-04-28 | 2026-04-24 | EWALD STEPHEN P | Insider | buy | $138.87 | 3,500 | 20,343 | $486K | SEC Form 4 |
| 2026-03-19 | 2026-03-18 | BURWIG SUSAN E | Insider | buy | $166.73 | 12,000 | 70,484 | $2.0M | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 57 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moMEDP contract awards, year to date.
Public federal awards linked to this ticker.
MEDP lobbying filings, year to date.
Registered lobbying filings matched to Medpace Holdings Inc.